Washington, D.C. – After thoughtful consideration of the petition, public comments, and petitioner responses, the Board of Pharmacy Specialties (BPS) Board of Directors voted to not approve pharmacy administration and leadership as a new pharmacy specialty certification.
BPS received the petition to recognize pharmacy administration and leadership as a specialty certification and opened the public comment period in July 2025 via a press release.
“The BPS Board believes that pharmacy administration and leadership is an important area in health care delivery. The decision to not approve this area as a pharmacy specialty certification does not limit the potential opportunity to request a new pharmacy specialty and submit a subsequent petition to BPS in the future,” said Gary C. Yee, PharmD, FCCP, FAPhA, BPS Board of Directors Chair.
More information about how BPS reviews new specialty certification programs can be found here.
About the Board of Pharmacy Specialties
The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of multidisciplinary healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. As of the end of 2024, BPS recognized more than 62,250 pharmacist certifications across 15 specialties.
BPS Contact
Alexander Jean-Baptiste
Associate Director, Digital Marketing and Communications
ajeanbaptiste@aphanet.org
(202) 760-3836